Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR).

Autor: Klebe S; Department of Anatomical Pathology, Flinders University and SA Pathology, Adelaide, SA, Australia., Judge M; International Collaboration on Cancer Reporting, Sydney, NSW, Australia., Brcic L; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Dacic S; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Galateau-Salle F; Department of Biopathology, Centre Léon Bérard, Lyon, France., Nicholson AG; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., Roggli V; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Nowak AK; Medical School, University of Western Australia, Crawley, WA, Australia., Cooper WA; Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.; Sydney Medical School, University of Sydney, Camperdown, NSW, Australia.; Discipline of Pathology, School of Medicine, Western Sydney University, Sydney, NSW, Australia.
Jazyk: angličtina
Zdroj: Histopathology [Histopathology] 2024 Mar; Vol. 84 (4), pp. 633-645. Date of Electronic Publication: 2023 Dec 04.
DOI: 10.1111/his.15106
Abstrakt: Aims: Mesothelioma is a rare malignancy of the serosal membranes that is commonly related to exposure to asbestos. Despite extensive research and clinical trials, prognosis to date remains poor. Consistent, comprehensive and reproducible pathology reporting form the basis of all future interventions for an individual patient, but also ensures that meaningful data are collected to identify predictive and prognostic markers.
Methods and Results: This article details the International Collaboration on Cancer Reporting (ICCR) process and the development of the international consensus mesothelioma reporting data set. It describes the 'core' and 'non-core' elements to be included in pathology reports for mesothelioma of all sites, inclusive of clinical, macroscopic, microscopic and ancillary testing considerations. An international expert panel consisting of pathologists and a medical oncologist produced a set of data items for biopsy and resection specimens based on a critical review and discussion of current evidence, and in light of the changes in the 2021 WHO Classification of Tumours. The commentary focuses particularly upon new entities such as mesothelioma in situ and provides background on relevant and essential ancillary testing as well as implementation of the new requirement for tumour grading.
Conclusion: We recommend widespread and consistent implementation of this data set, which will facilitate accurate reporting and enhance the consistency of data collection, improve the comparison of epidemiological data, support retrospective research and ultimately help to improve clinical outcomes. To this end, all data sets are freely available worldwide on the ICCR website (www.iccr-cancer.org/data-sets).
(© 2023 The Authors. Histopathology published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: